Daniel Payne
Washington Correspondent at STAT
Washington Correspondent @STATnews daniel.payne (at) statnews (dot) com Signal: danielp.100 @POLITICO / @OleMiss alum
Articles
-
1 week ago |
statnews.com | Jonathan Wosen |Daniel Payne
The Department of Health and Human Services on Friday released a summary of President Donald Trump’s budget request for the 2026 fiscal year that provides the most detailed look yet at how his administration hopes to reshape the National Institutes of Health and other federal agencies. The “budget in brief” document doubles down on a previous request to slash NIH’s discretionary budget to $27.5 billion, an $18 billion or nearly 40% reduction.
-
2 weeks ago |
ncregister.com | Daniel Payne
'America’s women and children deserve better and American taxpayers should have no role in funding these atrocities,' Ashley McGuire said. Speaker of the House Rep. Mike Johnson speaks as (left to right) House Republican Conference Chair Rep. Lisa McClain, Rep. Jason Smith, Rep. Jim Jordan, Rep. Mark Green, House Majority Leader Rep. Steve Scalise, and House Majority Whip Rep.
-
2 weeks ago |
statnews.com | Helen Branswell |Daniel Payne
Sen. Lisa Blunt Rochester has written a stinging letter to Health Secretary Robert F. Kennedy Jr. demanding that he clarify whether the Centers for Disease Control and Prevention has an acting director. In her three-page missive, Blunt Rochester suggested that Matthew Buzzelli, the person Kennedy said was the CDC’s acting director, cannot hold the role because he isn’t qualified under the federal Vacancies Act.
-
2 weeks ago |
bostonglobe.com | Daniel Payne
This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. The Trump administration shared on Tuesday the outlines of how it plans to push pharmaceutical companies to lower their US drug prices to bring them more in line with other nations, kicking off high-stakes negotiations with the companies.
-
2 weeks ago |
statnews.com | Daniel Payne
The Trump administration shared on Tuesday the outlines of how it plans to push pharmaceutical companies to lower their U.S. drug prices to bring them more in line with other nations, kicking off high-stakes negotiations with the companies. The Department of Health and Human Services will aim to negotiate drug prices down to the lowest prices paid by peer nations, and the pricing targets will apply to brand-name drugs that don’t face competition from generics or biosimilars.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 1K
- Tweets
- 585
- DMs Open
- Yes
RT @rickberke: One employee at the NIH told STAT they were “100% sure” Kennedy’s assertion before Congress was false. https://t.co/30W2ZXM…
In combative hearings, Kennedy defends HHS cuts, backtracks — and lashes out https://t.co/FsQgclzyEq
While praising the MAHA agenda, some Republicans share concerns with RFK Jr. about his sweeping changes at HHS https://t.co/gwuj0HaIDj